Clinical Trial Update: Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating hepatic intra-arterial ipilimumab in combination with intravenous nivolumab for advanced hepatocellular carcinoma is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• OPDIVO (nivolumab)
• Yervoy (ipilimumab)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: RECRUITING